(PFE) Pfizer Stock Price Forecast for 2024, 2025-2026, and Beyond

In the ever-evolving pharmaceutical landscape, Pfizer (NYSE: PFE) is a key player, with its stock forecast garnering significant interest from investors and analysts alike. Heading into 2024 and beyond, the consensus tilts towards a cautiously optimistic outlook for Pfizer's stock. This optimism is underpinned by the company's strong product lineup, including vital pharmaceuticals and promising new treatments and vaccines. While analysts offer varied price targets, they anticipate potential growth in Pfizer's stock value. 

However, investors should note the industry's sensitivity to regulatory shifts, competitive dynamics, and broader economic factors, which can influence stock trajectories. As we delve deeper into the details of Pfizer's financial and market position, this article will provide a comprehensive analysis of the factors influencing Pfizer's stock forecast and future forecasts about PFE stock price. This will offer insights to guide investors in making informed decisions in the dynamic world of pharmaceutical investing.

The article covers the following subjects:


Main takeaways: (PFE) Pfizer Stock Price Forecast 2024-2030

  • Current price: $27.69 (As of today, 12.02.2024)

  • 2024 year-end forecast: $33.204 (WalletInvestor), range of $30.009–$32.244 over the year. Modest but steady growth is anticipated based on financial position.

  • 2025 year-end forecast: $34.270 (WalletInvestor), range of $31.071–$34.270. Continued modest yearly growth is expected through small rises.

  • 2027-2030 long-term forecast: Contrasting predictions of $290.633 (GovCapital) by 2028 and $35.749 (WalletInvestor). GovCapital foresees a robust upward trajectory based on growth potential, while WalletInvestor expects more conservative, moderate gains.

PFE Stock Price Today Coming Days and Week

When analyzing Pfizer's stock price (PFE) for the short term, consider these technical analysis tools:

  • Moving Averages: Utilize short-term moving averages (e.g., 5-day and 10-day) to identify current price trends and potential crossover points for buy or sell signals.

  • Relative Strength Index (RSI): Monitor the RSI for indications of overbought ( > 70) or oversold ( < 30) conditions, which might signal impending price reversals.

  • MACD (Moving Average Convergence Divergence): Look for crossovers between the MACD line and the signal line, as well as divergence with price, to identify momentum shifts.

  • Bollinger Bands: These bands can help assess market volatility. A price touching or breaking through the bands may indicate overextended moves, suggesting potential pullbacks or reversals.

  • Volume Analysis: Analyze trading volume to confirm the strength of a price move. An uptrend with increasing volume can indicate strong buyer interest, and vice versa for downtrends.

  • Candlestick Patterns: Pay attention to short-term candlestick patterns, such as doji, hammer, or engulfing patterns, which can offer insights into market sentiment and potential reversals.

  • Fibonacci Retracements: Use these to identify possible support and resistance levels based on past price movements, providing targets for short-term trades.

When forecasting the price of Pfizer Inc. for the upcoming week, consider the following factors:

  • Healthcare Sector Trends: Analyze overall market trends within the healthcare and pharmaceutical sectors, as they can significantly impact Pfizer's stock.

  • Regulatory News: Stay informed about any FDA approvals, clinical trial results, or regulatory developments related to Pfizer's products, as these events can cause significant price movements.

  • Economic Indicators: Global and national economic conditions, such as changes in healthcare policy or insurance coverage, can affect pharmaceutical companies like Pfizer.

  • Company News: Monitor Pfizer's press releases and news for updates on drug development, partnerships, or earnings reports that could influence investor sentiment.

  • Technical Analysis: Use technical indicators like Moving Averages to understand trend direction, RSI for overbought or oversold conditions, and MACD for momentum insights.

  • Market Sentiment: Gauge investor sentiment and analyst opinions on Pfizer, as positive or negative outlooks can sway stock prices.

  • Global Events: Consider the impact of global health events or geopolitical developments, especially those related to the pharmaceutical industry, on Pfizer's business and stock price.

Combining these insights can provide a comprehensive view for predicting Pfizer's stock price movement over the week.

About the Pfizer Stock

Pfizer (NASDAQ: PFE) traces its origins to 1849, but it finally became a publicly-traded company in 1942, nearly a century after its founding. The $5.9 million IPO was one of the largest of that year, with shares valued at a price of $24.75 apiece. On the very first day, the company reached the market cap of $12.4 million.

At the time of its incorporation, the chemical enterprise was valued at $2 million. Today, the market cap has reached $215 billion, and it’s still one of the largest manufacturers and distributors of pharmaceuticals, agricultural and animal health products, pharmaceutical chemicals, nutritional products, and items for personal, household, and industrial use.

Currently, Pfizer is a component of the following U.S. stock market indices:

Pfizer stock price for today (12.02.2024) is $27.69. You can refer back to this article to see Pfizer stock price tomorrow.

Below is an interactive PFE-to-dollar real time price chart that shows the PFE stock rate for buying and selling: 

Pfizer Price in 2024: Forecasts From Experts

Let's take a look at expert forecasts for the PFE rate in 2024.

Gov Capital's 2024 Forecast for Pfizer’s Stock Price

Price Range for 2024: $21.20–$84.47

Gov.Capital projects a significant appreciation in Pfizer's stock (PFE) for 2024, estimating an average target of $68.98, a notable increase from its current price. This prediction suggests a potential growth of approximately 129% within the following year. Despite recent downtrends in Pfizer’s stock, Gov.Capital views it as a potentially lucrative addition to investment portfolios, indicating expectations of a bullish market ahead for Pfizer​​.

Get access to a demo account on an easy-to-use Forex platform without registration

Go to Demo Account

WalletInvestor's 2024 Forecast for Pfizer’s Stock Price

Price Range for 2024: $30.009–$32.244

Walletinvestor.com offers a more tempered outlook for Pfizer's stock in 2024, with monthly closing prices ranging from $30.13 to $33.02. Their forecast indicates a gradual, modest increase, with the stock price expected to reach $33.204 by the end of 2024. This analysis shows a fluctuating trend with up-and-down movements throughout 2024. The most significant monthly increase is anticipated in November, with a 4.84% rise. Walletinvestor.com's forecast suggests a stable but modest long-term growth for Pfizer's stock, aligning with a cautious investment strategy​​.


Minimum price

Maximum price


January 2024



-3.73 %▼

February 2024



-1.91 %▼

March 2024



2.25 % ▲

April 2024



-0.34 %▼

May 2024



0.39 % ▲

June 2024



-1.46 %▼

July 2024



2.59 % ▲

August 2024



-1.2 %▼

September 2024



-1.32 %▼

October 2024



1.04 % ▲

November 2024



4.84 % ▲

December 2024



1.63 % ▲

Pfizer (PFE) Stock Technical Analysis

Pfizer's share price has fluctuated wildly in recent years. #PFE has shown rapid growth during the pandemic and a subsequent decline since the end of 2022. The downtrend is not expected to reverse. However, dividends on the instrument continue to grow. Most sources agree that it is worth waiting and then entering purchases with a target of $35.94. The next expected resistance level is around $23.21. Let's use the SMA and RSI indicators for analysis.

The RSI level is 38, and the major moving averages indicate a sale. In general, bearish sentiment prevails in the market.

Pfizer stock price analysis for 3 months 

Technical analysis for 3 months was done using the Ichimoku indicator on the daily timeframe.

In the chart above, the Kijun-sen line is above the Tenkan-sen line. Both lines are horizontal. The cloud is descending, and the instrument is trading below it. The Chikou span line is located under the price chart and crosses it from top to bottom. The instrument tried to break out the cloud and start growing, but could not consolidate. All signs point to a further price decline.

Long-term Pfizer stock price analysis for 2024

It is very difficult to make a long-term forecast for #PFE. The instrument's price continues to fall, and no reversal occurs despite forecasts. The company continues to produce new medicines, but its main product, the COVID-19 vaccine, is becoming less and less in demand, which affects its overall capitalization. According to almost any oscillator, the price will continue to fall. Pfizer's recent acquisition of Seagen provides some hope for growth.

Let's consider two scenarios for #PFE shares for 2024. For this purpose, the Bollinger bands and Pivot Points indicators were used. Below is an optimistic forecast.

Here, the level of $31.51 will serve as the target. However, this scenario entirely depends on the company's new patents. At the moment, Pfizer's developments are disappointing.

According to a less optimistic forecast, the target would be $29.56. The table below shows the estimated highs and lows for 2024.


Pfizer Inc. stock price forecast (#PFE)

Minimum, $

Maximum, $

February 2024



March 2024



April 2024



May 2024



June 2024



July 2024



August 2024



September 2024



October 2024



November 2024



December 2024



Long-term trading plan for Pfizer Inc. (#PFE)

Taking into account technical analysis and general market sentiment, #PFE should be used as a long-term investment instrument. The price has been falling for a long time. Thus, many expect a reversal in the near future. However, there are no prerequisites for this.

  • Do not expect any sudden price movements in the next three months. Watch the market to understand whether the instrument will break out the upper border of the channel and be able to consolidate there.

  • By mid-spring 2024, if the instrument reverses, it will be profitable to enter purchases around $30.45.

  • If this does not happen, then the #PFE price will most likely continue to fall. Therefore, further focus on the support level of $23.21.

  • It is also worth paying attention to news regarding further company acquisitions or the release of new patents, as they will contribute to a trend reversal.

Please remember that this plan is a recommendation. It is very difficult to make long-term forecasts, especially in the current market conditions. Always conduct technical and fundamental analysis before making trading decisions.

Pfizer Price Forecast for 2025

Let's take a look at expert forecasts for the PFE rate in 2025.

Gov Capital's 2025 Forecast for Pfizer’s Stock Price

Price Range for 2025: $53.42–$136.90

The 2025 forecast for Pfizer's stock from Gov.Capital indicates a positive trend with a significant price increase. The prediction for January 2025 starts with an opening price of $72.679, suggesting a substantial growth from the 2024 forecast. The forecast range for the opening day of 2025 spans from a minimum of $61.77 to a maximum of $83.58, showing notable volatility and potential for high gains. This implies confidence in Pfizer's long-term growth and potential as a valuable asset in investment portfolios​​. Gov.Capital foresees that Pfizer’s stock will reach an average price of $117.994 at the end of 2025. 

WalletInvestor's 2025 Forecast for Pfizer’s Stock Price

Price Range for 2025: $31.071–$34.270

Walletinvestor.com's forecast for Pfizer's stock in 2025 shows a more conservative trend than Gov.Capital's prediction. The forecast for February 2025 starts with an opening price of $31.671 and a closing price of $31.245, indicating a slight decrease. However, subsequent months, like March and July, show a positive trend, with closing prices of $31.923 and $32.230, respectively. This forecast suggests a modest but steady yearly increase, with occasional fluctuations. Walletinvestor.com's prediction aligns with a more cautious and stable growth outlook for Pfizer's stock, focusing on incremental gains rather than significant spikes​​.


Minimum price

Maximum price

January 2025



February 2025



March 2025



April 2025



May 2025



June 2025



July 2025



August 2025



September 2025



October 2025



November 2025



December 2025



Pfizer Price Forecast for 2026

Let's take a look at expert forecasts for the PFE rate in 2026.

WalletInvestor's 2026 Forecast for Pfizer’s Stock Price

Price Range for 2026: $ 28.780–$30.684

Based on Walletinvestor's data, Pfizer's stock price is expected to experience fluctuations through 2026. Starting at $30.182 in January, it faces a downward trend until March, dropping to $29.007, before rebounding to $29.711. The trend continues with minor ups and downs, reaching a low of $28.902 in October. However, it recovers towards year-end, climbing to $30.669 in December, suggesting a volatile yet gradually upward trajectory over the year.


Opening price

Closing price

Minimum price

Maximum price


January 2026





-1.46 %▼

February 2026





-1.73 %▼

March 2026





2.37 % ▲

April 2026





-0.72 %▼

May 2026





0.26 % ▲

June 2026





-1.85 %▼

July 2026





2.52 % ▲

August 2026





-1.52 %▼

September 2026





-1.47 %▼

October 2026





1.13 % ▲

November 2026





2.6 % ▲

December 2026





1.86 % ▲

LongForecast's 2026 Forecast for Pfizer’s Stock Price

Price Range for 2026: $18.13–$31.35

According to LongForecast, Pfizer's stock is projected to experience a consistent downward trend through 2026. Beginning at $31.35 in January, the stock faces a significant decline, reaching $27.03, a 6.1% decrease. The decline continues each month, with lows ranging from $18.13 to $31.35. By December, the stock closes at $19.71, marking a substantial 31.5% drop from January, indicating a challenging year for Pfizer's stock value.


































































What Will Pfizer Stock Be Worth in 2027-2030?

Two contrasting views emerge when assessing the Pfizer stock predictions for 2027-2030. Gov Capital, utilizing deep learning algorithms, suggests an optimistic trend, with their forecast pointing towards a significant upward trajectory, as evidenced by their 2028 prediction of 290.633 USD. This implies a robust growth potential for Pfizer in the latter half of the decade.

On the other hand, Walletinvestor.com presents a more conservative outlook. They predict a moderate increase in Pfizer's stock value, projecting it to reach 35.749 USD by 2028. This forecast indicates a steadier, albeit less aggressive, growth than Gov Capital's estimation. Their analysis leans towards a moderately positive trend for Pfizer's stock in 2026-2030, suggesting a more cautious investment approach.

Pfizer’s Stock Price Changes Over Time

Pfizer's stock price journey, encapsulated over decades, showcases the dynamic interplay between company performance, market trends, and external factors. From a modest beginning in the late 1970s, the stock gradually grew, often mirroring broader market trends and Pfizer's developments. The 1990s marked significant growth, attributed to successful drug launches and robust pharmaceutical industry trends. However, the early 2000s presented challenges, with stock fluctuations reflecting broader market uncertainties and specific concerns like patent expirations.

Critical influences on Pfizer's stock include earnings reports, dividend announcements, and FDA approvals. The company's financial performance, such as revenue and EPS, significantly impacts investor decisions. Pfizer's role in developing treatments and vaccines also shapes market sentiment, reflecting the intricate relationship between company activities and stock performance.

Main Factors That Drive Pfizer (PFE) in 2024 & in the Future

The company's success hinges on its ability to adapt to various external factors that influence its operations and strategic decisions. Here are the main factors driving Pfizer:

  • Political Factors: Government regulations, healthcare policies, intellectual property rights, and political stability significantly impact Pfizer's business operations and profitability.

  • Economic Factors: Global economic conditions, currency exchange rates, interest rates, and healthcare spending trends are crucial in shaping Pfizer's financial performance.

  • Sociocultural Factors: Demographic shifts, health consciousness, cultural attitudes towards medicine, and social movements influence consumer preferences and demand for Pfizer's products.

  • Technological Factors: Innovations in R&D, drug manufacturing technologies, and digital health trends are essential to Pfizer's competitive edge and future growth.

  • Environmental Factors: Waste management, sustainable resource use, and compliance with environmental regulations are vital for Pfizer's operational efficiency and corporate responsibility.

  • Legal Factors: Drug approval regulations, IP rights, litigation risks, and compliance with advertising and data protection laws are essential considerations for Pfizer's legal and ethical operations.

Is Pfizer a Good Long-Term Investment?

As we head into the end of 2024, Pfizer stock presents a compelling case for investors. Backed by its success in COVID-19 vaccines and other pharmaceutical innovations, Pfizer has demonstrated strong earnings growth and robust sales. Wall Street analysts maintain a positive outlook, with a favorable analyst price target suggesting potential growth in the stock price.

Investors should note the risks inherent in the pharmaceutical industry, including regulatory challenges. However, Pfizer's solid earnings per share (EPS), consistent dividend yield, and strategic R&D investments in immunology and therapeutics enhance its appeal.

Pfizer Stock Forecast FAQ

Price chart of PFE in real time mode

The content of this article reflects the author’s opinion and does not necessarily reflect the official position of LiteFinance. The material published on this page is provided for informational purposes only and should not be considered as the provision of investment advice for the purposes of Directive 2004/39/EC.

Rate this article:

{{value}} ( {{count}} {{title}} )

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top